ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Final NHS nod for Roche’s RoActemra
July 16, 2018Roche/Chugai’s RoActemra should be routinely offered throughout the NHS to adults with giant cell arteritis (GCA) within the next three months, following a final green light from cost regulators. -
European Commission approves Roche’s tocilizumab to treat giant cell arteritis
September 26, 2017Roche’s Actemra / RoActemra (tocilizumab) has received approval from the European Commission (EC) to treat giant cell arteritis (GCA). -
US FDA accepts Genentech Actemra’s sBLA for Giant Cell Arteritis
January 26, 2017The US Food and Drug Administration (FDA) has accepted Genentech’s supplemental biologics licence application (sBLA) for Actemra (tocilizumab) for the treatment of Giant Cell Arteritis (GCA).
Pharma Sources Insight January 2025
